PT95760A - Metodo para o tratamento de perturbacoes relacionadas com a ansiedade usando sertralina - Google Patents

Metodo para o tratamento de perturbacoes relacionadas com a ansiedade usando sertralina

Info

Publication number
PT95760A
PT95760A PT95760A PT9576090A PT95760A PT 95760 A PT95760 A PT 95760A PT 95760 A PT95760 A PT 95760A PT 9576090 A PT9576090 A PT 9576090A PT 95760 A PT95760 A PT 95760A
Authority
PT
Portugal
Prior art keywords
perturbacins
sertraline
treatment
anxiety related
anxiety
Prior art date
Application number
PT95760A
Other languages
English (en)
Other versions
PT95760B (pt
Inventor
Decaln P Doogan
Karen A Scappaticci
Elizabeth Hackett
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23710001&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT95760(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer filed Critical Pfizer
Publication of PT95760A publication Critical patent/PT95760A/pt
Publication of PT95760B publication Critical patent/PT95760B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Anesthesiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PT95760A 1989-11-02 1990-10-31 Utilizacao de sertralina na preparacao de um medicamento para o tratamento de perturbacoes relacionadas com a ansiedade PT95760B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/431,000 US4962128A (en) 1989-11-02 1989-11-02 Method of treating anxiety-related disorders using sertraline

Publications (2)

Publication Number Publication Date
PT95760A true PT95760A (pt) 1991-09-13
PT95760B PT95760B (pt) 1997-12-31

Family

ID=23710001

Family Applications (1)

Application Number Title Priority Date Filing Date
PT95760A PT95760B (pt) 1989-11-02 1990-10-31 Utilizacao de sertralina na preparacao de um medicamento para o tratamento de perturbacoes relacionadas com a ansiedade

Country Status (17)

Country Link
US (1) US4962128A (pt)
EP (4) EP1127571B1 (pt)
JP (1) JPH03153624A (pt)
KR (1) KR960016580B1 (pt)
AT (3) ATE327743T1 (pt)
AU (1) AU616127B2 (pt)
CA (1) CA2029065C (pt)
DE (3) DE69034149T2 (pt)
DK (3) DK1127571T3 (pt)
HU (1) HUT59305A (pt)
IE (4) IE20020410A1 (pt)
IL (1) IL96146A (pt)
MY (1) MY106075A (pt)
NZ (1) NZ235933A (pt)
PH (1) PH26836A (pt)
PT (1) PT95760B (pt)
ZA (1) ZA908768B (pt)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4940731A (en) * 1989-08-30 1990-07-10 Pfizer Inc. Method of treating premature ejaculation using sertraline
DK0415612T3 (da) * 1989-08-30 1993-12-13 Pfizer Anvendelse af sertralin til behandling af afhængigheder af kemiske stoffer
PT98628A (pt) * 1990-08-09 1992-06-30 Massachusetts Inst Technology Processo de composicoes farmaceuticas a base de por exemplo sertralina
US5457100A (en) * 1991-12-02 1995-10-10 Daniel; David G. Method for treatment of recurrent paroxysmal neuropsychiatric
US5597826A (en) 1994-09-14 1997-01-28 Pfizer Inc. Compositions containing sertraline and a 5-HT1D receptor agonist or antagonist
US5525347A (en) * 1995-01-31 1996-06-11 Medical University Of South Carolina Composition and methods for treating performance anxiety
US20040208926A1 (en) * 1997-07-01 2004-10-21 Pfizer Inc Solubilized sertraline compositions
US20030133974A1 (en) * 1997-07-01 2003-07-17 Curatolo William John Encapsulated solution dosage forms of sertraline
SK180499A3 (en) * 1997-07-01 2001-08-06 Pfizer Sertraline salts and sustained-release dosage forms of sertraline
AU761618B2 (en) * 1997-07-01 2003-06-05 Pfizer Inc. Sertraline salts and sustained-release dosage forms of sertraline
US6391922B1 (en) 1998-01-13 2002-05-21 Synchroneuron, Llc Treatment of posttraumatic stress disorder, obsessive-compulsive disorder and related neuropsychiatric disorders
DE19830201A1 (de) * 1998-07-07 2000-01-13 Boehringer Ingelheim Pharma Mittel mit antidepressiver Wirkung
US6727283B2 (en) * 1998-10-13 2004-04-27 Pfizer Inc. Sertraline oral concentrate
ID29845A (id) * 1998-10-13 2001-10-18 Pfizer Prod Inc Konsentrat oral sertralina
IL132500A0 (en) 1998-10-29 2001-03-19 Pfizer Prod Inc Stereoselective microbial reduction of a racemic tetralone
US6245782B1 (en) 1999-05-17 2001-06-12 Heartdrug Research L.L.C. Methods of inhibiting platelet activation with selective serotonin reuptake inhibitors
AR021155A1 (es) * 1999-07-08 2002-06-12 Lundbeck & Co As H Tratamiento de desordenes neuroticos
JP2003518487A (ja) 1999-12-23 2003-06-10 ファイザー・プロダクツ・インク ヒドロゲル駆動型積層薬物製剤
EA200301195A1 (ru) * 2001-05-01 2004-04-29 Х. Лундбекк А/С Применение энантиомерно чистого эсциталопрама
US20030119908A1 (en) * 2001-12-21 2003-06-26 Zambon Group S.P.A. Stable gabapentin compositions
IL163666A0 (en) 2002-02-22 2005-12-18 New River Pharmaceuticals Inc Active agent delivery systems and methods for protecting and administering active agents
US20040131672A1 (en) * 2003-01-07 2004-07-08 Nilobon Podhipleux Direct compression pharmaceutical composition containing a pharmaceutically active ingredient with poor flowing properties
US20050070577A1 (en) * 2003-07-03 2005-03-31 Pfizer Inc. Compositions containing a serotonin selective reuptake inhibitor and a 5-HT2A receptor antagonist
EP1737473A4 (en) * 2004-04-19 2009-08-26 Noven Therapeutics Llc COMBINATIONS OF LITHIUM AND USES THEREOF
KR20070009671A (ko) * 2004-05-06 2007-01-18 사이덱스 인크 세르트랄린 및 술포알킬 에테르 시클로덱스트린을 함유하는맛 마스킹된 제제
US7893053B2 (en) 2006-06-16 2011-02-22 Theracos, Inc. Treating psychological conditions using muscarinic receptor M1 antagonists
US20060257475A1 (en) * 2006-08-17 2006-11-16 Boehringer Ingelheim International Gmbh Stable Sertraline Hydrochloride Formulation and Method
GB0708818D0 (en) * 2007-05-08 2007-06-13 Portela & Ca Sa Compounds
AU2010215075B2 (en) 2009-02-20 2015-08-20 Palmaya Pty Ltd Pharmaceutical preparation and delivery system
US20100298397A1 (en) * 2009-05-19 2010-11-25 Singh Nikhilesh N Method of treatment of obsessive compulsive disorder with ondansetron
EP2875810A1 (en) * 2013-11-20 2015-05-27 Biocodex Pharmacological treatment of obsessive-compulsive disorder using Stiripentol or a similar compound

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4536518A (en) * 1979-11-01 1985-08-20 Pfizer Inc. Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
US4803076A (en) * 1986-09-04 1989-02-07 Pfizer Inc. Controlled release device for an active substance
JP2938463B2 (ja) * 1987-10-22 1999-08-23 マサチユセツツ・インスチチユート・オブ・テクノロジー 月経前又は後期黄体期症候群の処置
IL91398A (en) * 1988-08-30 1994-05-30 Pfizer A device for the controlled release of pneumatic substances, including the active substance, surrounded by an asymmetric membrane

Also Published As

Publication number Publication date
PT95760B (pt) 1997-12-31
PH26836A (en) 1992-11-05
US4962128A (en) 1990-10-09
IE20020411A1 (en) 2002-11-27
ATE327743T1 (de) 2006-06-15
CA2029065A1 (en) 1991-05-03
AU6571590A (en) 1991-08-01
IE20020410A1 (en) 2002-11-27
DE69034149T2 (de) 2004-09-30
IL96146A (en) 1995-10-31
ATE212223T1 (de) 2002-02-15
DE69034149D1 (de) 2004-07-22
HUT59305A (en) 1992-05-28
EP1129708A1 (en) 2001-09-05
EP0429189A3 (en) 1992-01-22
EP1127571A1 (en) 2001-08-29
KR960016580B1 (ko) 1996-12-16
NZ235933A (en) 1997-07-27
DE69034223T2 (de) 2006-11-02
DK1127571T3 (da) 2004-09-20
ATE269068T1 (de) 2004-07-15
IE20020409A1 (en) 2002-11-27
DK0429189T3 (da) 2002-02-11
EP0429189A2 (en) 1991-05-29
EP1125581A1 (en) 2001-08-22
IE903936A1 (en) 1991-05-08
HU907011D0 (en) 1991-05-28
DE69033903D1 (de) 2002-03-14
CA2029065C (en) 1994-11-08
KR910009252A (ko) 1991-06-28
DE69034223D1 (de) 2006-07-06
EP1129708B1 (en) 2006-05-31
MY106075A (en) 1995-03-31
IL96146A0 (en) 1991-07-18
JPH03153624A (ja) 1991-07-01
DK1129708T3 (da) 2006-08-07
AU616127B2 (en) 1991-10-17
ZA908768B (en) 1992-06-24
EP0429189B1 (en) 2002-01-23
EP1127571B1 (en) 2004-06-16

Similar Documents

Publication Publication Date Title
PT95760A (pt) Metodo para o tratamento de perturbacoes relacionadas com a ansiedade usando sertralina
DK0415613T3 (da) Anvendelse af sertralin til behandling af præmatur ejakulation
MX9205681A (es) Aminometil-cromanos, procedimiento para su fabricacion y medicamento que los contiene.
KR880012218A (ko) 캘폰 유도체를 사용한 다발성 경화증의 치료방법
PT867178E (pt) Utilizacao de agonistas nao alostericos de gaba para o tratamento de desordens do sono
BR0011578A (pt) Utilização do s-enantiÈmero de citalopram para tratamento de distúrbio de ansiedade geral ou ataques de pânico
DK0768083T3 (da) Anvendelse af sertralin til at behandle patienter med post myocardisk infarkt
MY106939A (en) A method of treating chemical dependencies using sertraline.
ATE222768T1 (de) Ctla-8 in kombination mit g-csf oder mit g-csf und il-6, und verwendung vom ctla-8 zur behandlung von infektionen
NO970607D0 (no) Anordning av selegilin i behandling av epileptiske tilstander
ATE245199T1 (de) Behandlung von influenzavirus-infektion unter verwendung von antiviralen acylierung/palmitylierung von hemagglutinin hemmen
ES2093515T3 (es) Aplicacion del riluzol como radio-restaurador.
MX9602793A (es) Uso de sertralina para tratar pacientes despues de un infarto de miocardio.
PT930879E (pt) Utilizacao de dobesilato de calcio para a preparacao de um medicamento para o tratamento de retardamento embrionario

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19910403

FG3A Patent granted, date of granting

Effective date: 19970917

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20090317